Athenex, Inc.

OTCPK:ATNX.Q 주식 보고서

시가총액: US$131.7k

Athenex 관리

관리 기준 확인 4/4

Athenex's CEO is Johnson Lau, appointed in Jan 2011, has a tenure of 12.75 years. total yearly compensation is $714.51K, comprised of 73.5% salary and 26.5% bonuses, including company stock and options. directly owns 2.99% of the company’s shares, worth $3.93K. The average tenure of the management team and the board of directors is 4.5 years and 4.9 years respectively.

주요 정보

Johnson Lau

최고 경영자

US$714.5k

총 보상

CEO 급여 비율73.5%
CEO 임기12.8yrs
CEO 소유권3.0%
경영진 평균 재임 기간4.5yrs
이사회 평균 재임 기간4.9yrs

최근 관리 업데이트

Recent updates

Athenex prices $30M in stock and warrants offering

Aug 11

Athenex surges 70% as Dr Reddy's and Intas race to form buyout deal

Aug 05

Athenex GAAP EPS, revenue misses estimates

Jul 28

Athenex to sell its China API business for $19M

Jul 11

Athenex: Is This Stock A Buy, Sell, Or Hold? It's A Hold.

Aug 31

Athenex EPS beats by $0.13, beats on revenue

May 06

Is Athenex (NASDAQ:ATNX) Weighed On By Its Debt Load?

Apr 04
Is Athenex (NASDAQ:ATNX) Weighed On By Its Debt Load?

Have Insiders Sold Athenex, Inc. (NASDAQ:ATNX) Shares Recently?

Mar 09
Have Insiders Sold Athenex, Inc. (NASDAQ:ATNX) Shares Recently?

These Analysts Just Made A Sizeable Downgrade To Their Athenex, Inc. (NASDAQ:ATNX) EPS Forecasts

Mar 06
These Analysts Just Made A Sizeable Downgrade To Their Athenex, Inc. (NASDAQ:ATNX) EPS Forecasts

Have Insiders Been Buying Athenex, Inc. (NASDAQ:ATNX) Shares?

Feb 19
Have Insiders Been Buying Athenex, Inc. (NASDAQ:ATNX) Shares?

When Can We Expect A Profit From Athenex, Inc. (NASDAQ:ATNX)?

Jan 29
When Can We Expect A Profit From Athenex, Inc. (NASDAQ:ATNX)?

CEO 보상 분석

Johnson Lau 의 보수는 Athenex 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Dec 31 2022US$715kUS$525k

-US$98m

Sep 30 2022n/an/a

-US$178m

Jun 30 2022n/an/a

-US$192m

Mar 31 2022n/an/a

-US$198m

Dec 31 2021US$2mUS$525k

-US$158m

Sep 30 2021n/an/a

-US$132m

Jun 30 2021n/an/a

-US$135m

Mar 31 2021n/an/a

-US$144m

Dec 31 2020US$3mUS$161k

-US$142m

Sep 30 2020n/an/a

-US$118m

Jun 30 2020n/an/a

-US$116m

Mar 31 2020n/an/a

-US$108m

Dec 31 2019US$4mUS$519k

-US$123m

Sep 30 2019n/an/a

-US$129m

Jun 30 2019n/an/a

-US$141m

Mar 31 2019n/an/a

-US$145m

Dec 31 2018US$3mUS$500k

-US$117m

Sep 30 2018n/an/a

-US$119m

Jun 30 2018n/an/a

-US$96m

Mar 31 2018n/an/a

-US$97m

Dec 31 2017US$5mUS$500k

-US$131m

Sep 30 2017n/an/a

-US$143m

Jun 30 2017n/an/a

-US$144m

Mar 31 2017n/an/a

-US$118m

Dec 31 2016US$522kUS$200k

-US$88m

보상 대 시장: Johnson's total compensation ($USD714.51K) is about average for companies of similar size in the US market ($USD740.57K).

보상과 수익: Johnson's compensation has been consistent with company performance over the past year.


CEO

Johnson Lau (63 yo)

12.8yrs

테뉴어

US$714,505

보상

Dr. Yiu-Nam Lau, also known as Johnson, MBBS, MD, FRCP, Ph D., has been the Chief Executive Officer of Athenex, Inc. since 2011. Dr. Lau is the Vice Chairman and CEO of Axis Therapeutics.Dr. Lau serves as...


리더십 팀

이름위치테뉴어보상소유권
Yiu-Nam Lau
Chairman & CEO12.8yrsUS$714.51k2.99%
$ 3.9k
Jeffrey Yordon
COO & President of Athenex Pharmaceutical Division6.7yrsUS$524.66k0.14%
$ 186.9
Daniel Lang
President of Athenex Cell Therapy2.4yrsUS$481.15k0.047%
$ 62.0
Allen Barnett
Co-Founder & President Emeritus12.8yrs데이터 없음데이터 없음
Steven Adams
Chief Accounting Officer2.2yrsUS$289.28k0.0018%
$ 2.4
Caileigh Dougherty
Director of Investor Relationsno data데이터 없음데이터 없음
Jacqueline Li
Vice President of Alliance Management & Corporate Development3.8yrs데이터 없음데이터 없음
John Matthei
Chief Human Resource Officerno data데이터 없음데이터 없음
David Cutler
Deputy Chief Medical Officer of Biologics & Cell Therapy3.8yrs데이터 없음데이터 없음
Timothy Cook
Chief Business & Commercial Officer of Proprietary Drugs5.3yrs데이터 없음0.048%
$ 62.9
Nicholas Campbell
Chief Restructuring Officerless than a year데이터 없음데이터 없음
Li Shen
Vice President of Financial Planning & Treasury6.8yrs데이터 없음데이터 없음

4.5yrs

평균 재임 기간

59yo

평균 연령

경험이 풍부한 관리: ATNX.Q's management team is considered experienced (4.5 years average tenure).


이사회 구성원

이름위치테뉴어보상소유권
Yiu-Nam Lau
Chairman & CEO19.9yrsUS$714.51k2.99%
$ 3.9k
John Vierling
Independent Director4.5yrsUS$42.00k0.14%
$ 187.4
Jinn Wu
Independent Director16.5yrsUS$40.86k0.40%
$ 529.0
Robert Jay Spiegel
Independent Director3.2yrsUS$46.00k0.053%
$ 69.8
Kwan-Hung Tsang
Independent Director5.3yrsUS$55.14k0.20%
$ 257.2
Jordan Kanfer
Independent Director4.5yrsUS$42.00k0.0099%
$ 13.0
Manson Fok
Director8.3yrsUS$35.71k1.28%
$ 1.7k
Stephanie Davis
Lead Independent Director4.5yrsUS$46.00k0.093%
$ 121.8

4.9yrs

평균 재임 기간

64.5yo

평균 연령

경험이 풍부한 이사회: ATNX.Q's board of directors are considered experienced (4.9 years average tenure).